Adequan Equine I.M. 500mg/5ml 7 x 5ml Vials Box is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Package contains 7 Vials. Adequan Equine Proven to relieve the symptoms of osteoarthritis, Adequan (POLYSULFATED GLYCOSAMINOGLYCAN) breaks the destructive disease cycle, inhibits cartilage damage and stimulates the cartilage repair process. Adequan Equine Extensive studies of Adequan have proven it readily passes through the synovial membrane and is taken up into cartilage by diffusion. This results in the concentration and progressive accumulation of Adequan at the site of injury. Studies have not been conducted to establish safety in breeding horses. Not for use in horses intended for food.

ADEQUAN® I.M.
Rx
Luitpold
Brand of Polysulfated Glycosaminoglycan (PSGAG)
Solution 500 mg/5 mL
For Intramuscular Use In Horses

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION
Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH. Sodium Chloride may be added to adjust tonicity.

PHARMACOLOGY
Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic rocesses of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.

TOXICITY
Toxicity studies were conducted in horses. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no o reness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.

INDICATIONS
Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

CONTRAINDICATIONS
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.

WARNING
Not for use in horses intended for food.

DOSAGE AND ADMINISTRATION
The recommended dose of Adequan® i.m. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. with other drugs or solvents.

REPRODUCTIVE SAFETY
Studies have not been conducted to establish safety in breeding horses.

Dispose of spent needles in accordance with all federal, state and local environmental laws.

WARNING
Keep this and all medications out of the reach of children.

HOW SUPPLIED
Adequan® i.m. solution, 500 mg/5 mL is available in 5 mL glass vials.

STORAGE CONDITIONS
Store at controlled room temperature 18°-25°C (64°-77°F). Discard unused portion.

Adequan® i.m. (polysulfated glycosaminoglycan) is available only in an injectable, prescription form dispensed by licensed veterinarians. The recommended dose is 500 mg intramuscularly every four days for 28 days.

Studies have shown that two hours after the first Adequan® i.m. injection, beneficial levels are reached in the joint and therapeutic levels are present for up to 96 hours. To achieve maximum benefit of blocking cartilage destruction and stimulating joint repair processes, make sure your horse receives the entire seven doses recommended by your veterinarian.